Practical methods for incorporating summary time-to-event data into meta-analysis

被引:4883
作者
Tierney, Jayne F. [1 ]
Stewart, Lesley A.
Ghersi, Davina
Burdett, Sarah
Sydes, Matthew R.
机构
[1] MRC, Meta Anal Grp, Clin Trials Unit, London, England
[2] Univ York, Ctr Review & Disseminat, York YO10 5DD, N Yorkshire, England
[3] NHMRC, Clin Trials Ctr, Sch Publ Hlth, Sydney, NSW, Australia
[4] MRC, Canc Grp, London, England
基金
英国医学研究理事会;
关键词
D O I
10.1186/1745-6215-8-16
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: In systematic reviews and meta-analyses, time-to-event outcomes are most appropriately analysed using hazard ratios (HRs). In the absence of individual patient data (IPD), methods are available to obtain HRs and/or associated statistics by carefully manipulating published or other summary data. Awareness and adoption of these methods is somewhat limited, perhaps because they are published in the statistical literature using statistical notation. Methods: This paper aims to 'translate' the methods for estimating a HR and associated statistics from published time-to-event-analyses into less statistical and more practical guidance and provide a corresponding, easy-to-use calculations spreadsheet, to facilitate the computational aspects. Results: A wider audience should be able to understand published time-to-event data in individual trial reports and use it more appropriately in meta-analysis. When faced with particular circumstances, readers can refer to the relevant sections of the paper. The spreadsheet can be used to assist them in carrying out the calculations. Conclusion: The methods cannot circumvent the potential biases associated with relying on published data for systematic reviews and meta-analysis. However, this practical guide should improve the quality of the analysis and subsequent interpretation of systematic reviews and meta-analyses that include time-to-event outcomes.
引用
收藏
页数:16
相关论文
共 18 条
  • [1] REVIEW OF SURVIVAL ANALYSES PUBLISHED IN CANCER JOURNALS
    ALTMAN, DG
    DESTAVOLA, BL
    LOVE, SB
    STEPNIEWSKA, KA
    [J]. BRITISH JOURNAL OF CANCER, 1995, 72 (02) : 511 - 518
  • [2] [Anonymous], 1999, Lancet, V354, P533
  • [3] Empirical evidence for selective reporting of outcomes in randomized trials -: Comparison of Protocols to published articles
    Chan, AW
    Hróbjartsson, A
    Haahr, MT
    Gotzsche, PC
    Altman, DG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (20): : 2457 - 2465
  • [4] METAANALYSIS IN CLINICAL-TRIALS
    DERSIMONIAN, R
    LAIRD, N
    [J]. CONTROLLED CLINICAL TRIALS, 1986, 7 (03): : 177 - 188
  • [5] FACTORS INFLUENCING PUBLICATION OF RESEARCH RESULTS - FOLLOW-UP OF APPLICATIONS SUBMITTED TO 2 INSTITUTIONAL REVIEW BOARDS
    DICKERSIN, K
    MIN, YI
    MEINERT, CL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (03): : 374 - 378
  • [6] THE EXISTENCE OF PUBLICATION BIAS AND RISK-FACTORS FOR ITS OCCURRENCE
    DICKERSIN, K
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (10): : 1385 - 1389
  • [7] PUBLICATION BIAS IN CLINICAL RESEARCH
    EASTERBROOK, PJ
    BERLIN, JA
    GOPALAN, R
    MATTHEWS, DR
    [J]. LANCET, 1991, 337 (8746) : 867 - 872
  • [8] What is meant by intention to treat analysis? Survey of published randomised controlled trials
    Hollis, S
    Campbell, F
    [J]. BRITISH MEDICAL JOURNAL, 1999, 319 (7211) : 670 - +
  • [9] RANDOMIZED TRIAL IN ADVANCED OVARIAN-CANCER COMPARING CISPLATIN AND CARBOPLATIN
    MANGIONI, C
    BOLIS, G
    PECORELLI, S
    BRAGMAN, K
    EPIS, A
    FAVALLI, G
    GAMBINO, A
    LANDONI, F
    PRESTI, M
    TORRI, W
    VASSENA, L
    ZANABONI, F
    MARSONI, S
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (19) : 1464 - 1471
  • [10] Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO